/ /

  • linkedin
  • Increase Font
  • Sharebar

    Senator calls for changes to eyewear regulations

    Washington, DC—U.S. Senator Charles Schumer (D-NY) recently called on the Federal Trade Commission (FTC) to change regulations on eyeglasses prescriptions to promote competition in the eyecare industry and lower prices on eyewear.

    Schumer cites $300 as the average price for glasses and says the average American is now struggling to afford the price. He says current regulations limit competition because they do not require eyecare providers (ECPs) to provide complete prescriptions to patients or to verify prescription information to third-party dispensers and that this omission can limit consumer choice and lead to higher prices. Schumer believes that consumers should have the ability to shop around in search of a more affordable price and not be limited to the eyeglasses offered in the store where they get their eye exam.

    Related: 3 reasons why you sould love Warby Parker 

    “Eyeglasses are a necessity for millions of Americans, yet sky-high prices are making them unaffordable,” he says. “We need more oversight when it comes to the cost of eyeglasses, and one way to do that is to require patients get their full prescriptions so they can shop around in stores and online for the best deal. Consumers need more options when it comes to eyeglasses and that's why the FTC should update the 'Eyeglass Rule' in a way that helps spur competition and dramatically lower prices.”

    Next: Schumer's proposed changes

    Colleen E. McCarthy
    Colleen McCarthy is a freelance writer based in the Cleveland area and a former editor of Optometry Times. She is a 2010 graduate of the ...

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Optometry Times A/V